110 related articles for article (PubMed ID: 15765429)
21. Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.
Makris N; Crott R; Fallone CA; Bardou M; Barkun A
Gastrointest Endosc; 2003 Jul; 58(1):14-22. PubMed ID: 12838214
[TBL] [Abstract][Full Text] [Related]
22. Treating dyspepsia: new OTC drug changes the economic picture.
Dis Manag Advis; 2003 Oct; 9(10):133-4, 129. PubMed ID: 14679871
[TBL] [Abstract][Full Text] [Related]
23. CUSUM charts for monitoring clinical practice quality using primary care prescribing data: a case study of an initiative to encourage generic prescribing of proton pump inhibitors.
Wood J; Lambert MF
J Clin Pharm Ther; 2011 Dec; 36(6):680-6. PubMed ID: 21143614
[TBL] [Abstract][Full Text] [Related]
24. Management of outpatients with dyspepsia.
Millard P; Fitzpatrick BP
J Fam Pract; 1997 Sep; 45(3):199-200. PubMed ID: 9312557
[No Abstract] [Full Text] [Related]
25. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
[TBL] [Abstract][Full Text] [Related]
26. Eradicating Helicobacter pylori in non-ulcer dyspepsia may not be cost effective.
Formoso G; Maestri E; Magrini N; Koch M; Capurso L; Liberati A
BMJ; 2001 Mar; 322(7285):557. PubMed ID: 11263460
[No Abstract] [Full Text] [Related]
27. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
Yap PR; Mahadeva S; Goh KL
Aliment Pharmacol Ther; 2013 Nov; 38(10):1321-2. PubMed ID: 24134501
[No Abstract] [Full Text] [Related]
28. Proton pump inhibitors may mask early gastric cancer. Dyspeptic patients over 45 should undergo endoscopy before these drugs are started.
Griffin SM; Raimes SA
BMJ; 1998 Dec; 317(7173):1606-7. PubMed ID: 9848895
[No Abstract] [Full Text] [Related]
29. The dyspepsia alphabet: DU, GU, GERD, NERD, NUD/FD and UD.
Thomson AB
Can J Gastroenterol; 2001 Jan; 15(1):49-55. PubMed ID: 11173326
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of eradication of Helicobacter pylori in nonulcer dyspepsia in a population with a high prevalence of infection: results of a 12-month randomized, double blind, placebo-controlled study.
Mazzoleni LE; Sander GB; Ott EA; Barros SG; Francesconi CF; Polanczyk CA; Wortmann AC; Theil AL; Fritscher LG; Rivero LF; Cartell A; Edelweiss MI; Uchôa DM; Prolla JC
Dig Dis Sci; 2006 Jan; 51(1):89-98. PubMed ID: 16416218
[TBL] [Abstract][Full Text] [Related]
31. A second-order simulation model of the cost-effectiveness of managing dyspepsia in the United States.
Barton PM; Moayyedi P; Talley NJ; Vakil NB; Delaney BC
Med Decis Making; 2008; 28(1):44-55. PubMed ID: 18057189
[TBL] [Abstract][Full Text] [Related]
32. Should indirect costs and benefits be included?
Henry DA
Pharmacoeconomics; 1992 Jun; 1(6):462. PubMed ID: 10147025
[No Abstract] [Full Text] [Related]
33. Patient-directed strategy to reduce prescribing for patients with dyspepsia in general practice: a randomized trial.
Krol N; Wensing M; Haaijer-Ruskamp F; Muris JW; Numans ME; Schattenberg G; Balen J; Grol R
Aliment Pharmacol Ther; 2004 Apr; 19(8):917-22. PubMed ID: 15080853
[TBL] [Abstract][Full Text] [Related]
34. Commentary: rabeprazole improves symptoms in patients with functional dyspepsia in Japan - author's reply.
Iwakiri R
Aliment Pharmacol Ther; 2013 Nov; 38(10):1322-3. PubMed ID: 24134502
[No Abstract] [Full Text] [Related]
35. Dyspepsia management in the millennium: the death of test and treat?
Talley NJ
Gastroenterology; 2002 May; 122(5):1521-5. PubMed ID: 11984537
[No Abstract] [Full Text] [Related]
36. Functional dyspepsia: bye-bye to PPIs.
Nyrén O
Gut; 2002 Oct; 51(4):464-5. PubMed ID: 12235062
[No Abstract] [Full Text] [Related]
37. The effect of a Helicobacter pylori treatment strategy on health care expenditures in patients with peptic ulcer disease and dyspepsia.
Kearney DJ; Liu CF; Crump C; Brousal A
Am J Gastroenterol; 2003 Sep; 98(9):1952-62. PubMed ID: 14499771
[TBL] [Abstract][Full Text] [Related]
38. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors.
Raghunath AS; Hungin AP; Mason J; Jackson W
Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981
[TBL] [Abstract][Full Text] [Related]
39. [Tapering off is the most effective measure for protein pump inhibitor discontinuation].
Steurer J
Praxis (Bern 1994); 2015 Jan; 104(2):105. PubMed ID: 25586436
[No Abstract] [Full Text] [Related]
40. Cost-effective management of patients with dyspepsia.
Levy M; Evans MF
Can Fam Physician; 1998 Mar; 44():515-7. PubMed ID: 9559191
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
